COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, June 6, 2022 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
368 new cases, bringing the total number of people infected to 1,069,520*;
1 new deaths reported in the last 24 hours, for a total of 15,450 deaths;
3,670 health care workers absent for COVID-related reasons (preventive withdrawal, isolation, awaiting results, etc.);
Hospitalizations and intensive care: due to a change in methodology, data are no longer compiled on weekends. Thus, the data will be updated from Tuesday to Saturday.
8,208 samples conducted on June 4;
216,065 self-declared rapid tests so far, including 177,280 positive: 216 declared for yesterday, including 186 positive.
*Note that the number of cases listed is not representative of the situation since access to screening centres is restricted to priority clienteles.
Vaccination
2,093 doses administered are added, that is 2,087 doses in the last 24 hours and 6 doses before June 5, for a total of 19,941,590 doses administered in Québec. Outside Québec, a total of 337,493 doses were administered, for a cumulative total of 20,279,083 doses received by Quebecers.
To follow the evolution of the data on a daily basis, consult the open data or the INSPQ website at https://www.donneesquebec.ca/recherche/fr/organization/msss or at https://www.inspq.qc.ca/covid-19/donnees. Note that certain data, especially the number of cases, deaths and doses administered, may be subject to daily readjustment for previous days, given that a catch-up is necessary due to a delay in data entry.
A reminder concerning public health instructions:
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
Qomolangma Acquisition Corp. (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-K for the period ended December 31, 2023,...
Caris Life Sciences® (Caris), the leading next-generation AI TechBio company and precision medicine pioneer, today announced that the company and collaborators from the biopharma industry and leading cancer centers, including those within the Caris...
MolecuLight Inc., the pioneer in point-of-care fluorescence imaging for real-time detection of elevated bacterial loads in wounds, proudly announces the presentation of findings from multiple MolecuLight studies in nine clinical posters at the...
FogPharma®, a clinical-stage biopharmaceutical company dedicated to delivering a new class of therapies that go beyond the limits of currently available medicines using its Helicontm peptide platform, and ARTBIO, Inc. ("ARTBIO"), a clinical-stage...
Rockwell Medical, Inc. (the "Company") , a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the...
Aurinia Pharmaceuticals Inc. (Aurinia or the Company), today announced the presentation of results from an updated cost-effective analysis of LUPKYNIS (voclosporin), a second generation calcineurin inhibitor (CNI), at the annual National Kidney...